Longevity of Middle East Respiratory Syndrome Coronavirus Antibody Responses in Humans, Saudi Arabia
Understanding the immune response to Middle East respiratory syndrome coronavirus (MERS-CoV) is crucial for disease prevention and vaccine development. We studied the antibody responses in 48 human MERS-CoV infection survivors who had variable disease severity in Saudi Arabia. MERS-CoV-specific neutralizing antibodies were detected for 6 years postinfection.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:27 |
|---|---|
| Enthalten in: |
Emerging infectious diseases - 27(2021), 5 vom: 02. Mai |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Alshukairi, Abeer N [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 18.06.2021 Date Revised 01.02.2022 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.3201/eid2705.204056 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM324544049 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM324544049 | ||
| 003 | DE-627 | ||
| 005 | 20231225190538.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3201/eid2705.204056 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1081.xml |
| 035 | |a (DE-627)NLM324544049 | ||
| 035 | |a (NLM)33900908 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Alshukairi, Abeer N |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Longevity of Middle East Respiratory Syndrome Coronavirus Antibody Responses in Humans, Saudi Arabia |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 18.06.2021 | ||
| 500 | |a Date Revised 01.02.2022 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Understanding the immune response to Middle East respiratory syndrome coronavirus (MERS-CoV) is crucial for disease prevention and vaccine development. We studied the antibody responses in 48 human MERS-CoV infection survivors who had variable disease severity in Saudi Arabia. MERS-CoV-specific neutralizing antibodies were detected for 6 years postinfection | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, N.I.H., Extramural | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a MERS | |
| 650 | 4 | |a MERS-CoV | |
| 650 | 4 | |a Middle East respiratory syndrome | |
| 650 | 4 | |a Middle East respiratory syndrome coronavirus | |
| 650 | 4 | |a Saudi Arabia | |
| 650 | 4 | |a antibody responses | |
| 650 | 4 | |a coronaviruses | |
| 650 | 4 | |a disease severity | |
| 650 | 4 | |a humans | |
| 650 | 4 | |a longevity | |
| 650 | 4 | |a patients | |
| 650 | 4 | |a viruses | |
| 650 | 4 | |a zoonoses | |
| 700 | 1 | |a Zhao, Jincun |e verfasserin |4 aut | |
| 700 | 1 | |a Al-Mozaini, Maha A |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Yanqun |e verfasserin |4 aut | |
| 700 | 1 | |a Dada, Ashraf |e verfasserin |4 aut | |
| 700 | 1 | |a Baharoon, Salim A |e verfasserin |4 aut | |
| 700 | 1 | |a Alfaraj, Sara |e verfasserin |4 aut | |
| 700 | 1 | |a Ahmed, Waleed A |e verfasserin |4 aut | |
| 700 | 1 | |a Enani, Mushira A |e verfasserin |4 aut | |
| 700 | 1 | |a Elzein, Fatehi E |e verfasserin |4 aut | |
| 700 | 1 | |a Eltayeb, Nazik |e verfasserin |4 aut | |
| 700 | 1 | |a Layqah, Laila |e verfasserin |4 aut | |
| 700 | 1 | |a El-Saed, Aiman |e verfasserin |4 aut | |
| 700 | 1 | |a Bahaudden, Husam A |e verfasserin |4 aut | |
| 700 | 1 | |a Haseeb, Abdul |e verfasserin |4 aut | |
| 700 | 1 | |a El-Kafrawy, Sherif A |e verfasserin |4 aut | |
| 700 | 1 | |a Hassan, Ahmed M |e verfasserin |4 aut | |
| 700 | 1 | |a Siddiq, Najlaa A |e verfasserin |4 aut | |
| 700 | 1 | |a Alsharif, Ibtihaj |e verfasserin |4 aut | |
| 700 | 1 | |a Qushmaq, Isamel |e verfasserin |4 aut | |
| 700 | 1 | |a Azhar, Esam I |e verfasserin |4 aut | |
| 700 | 1 | |a Perlman, Stanley |e verfasserin |4 aut | |
| 700 | 1 | |a Memish, Ziad A |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Emerging infectious diseases |d 1995 |g 27(2021), 5 vom: 02. Mai |w (DE-627)NLM088704254 |x 1080-6059 |7 nnns |
| 773 | 1 | 8 | |g volume:27 |g year:2021 |g number:5 |g day:02 |g month:05 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3201/eid2705.204056 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 27 |j 2021 |e 5 |b 02 |c 05 | ||